Login
Enter your username or email address.

Request new password

Home

Progress in Mind Middle East and Africa

  • Topics
    • COVID-19 Pandemic
    • Alcohol Dependance
    • Alzheimer's Disease
    • Bipolar Disease
    • Depression
    • Schizophrenia
    • Parkinson's Disease
    • Migraine
  • Congress highlights
    • ECNP 2022
    • ASUIP 2022
    • EAN 2022
    • COVID-19 MEA
    • ECNP 2021
    • EAN 2021
    • APA 2019
  • Expert Views
  • Podcast
  • About Us

The information on this site is exclusively intented for health care professionals.

ACCEPT DECLINE
10 Jul, 2020 Read Time: 2 mins

How should treatment be tailored for the DSM-5 mixed features specifier?

Sign up for Progress in Mind Middle East and Africa

Sign up for our newsletter and stay updated on new content and resources.

Related

Schizophrenia
Article

LAIs: old, classic, vintage or valuable?

Depression Bipolar
Article

Inform, track and treat: New tools to identify and address cognitive symptoms in mood disorders

Schizophrenia
Article

Taper or maintain antipsychotics in schizophrenia?

Social Networks

Tags

  • Assessment
  • Diagnosis
  • Disease management
  • DSM-5
  • Patient management
  • Treatment
  • Guidelines
  • Mixed features specifier
  • CANMAT
  • ISBD

Progress in Mind Middle East and Africa HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Middle East and Africa click here.

Register Already registered

Brought to you by

 Lundbeck

© 2022 Lundbeck Middle East and Africa

PROGRESS IN MIND MIDDLE EAST & AFRICA

Cookies

Privacy Information and Disclaimer

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue